Patents by Inventor Katayoon Hojjati-Emami

Katayoon Hojjati-Emami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of ?-catenin/TCF-activated transcription
    Patent number: 7531320
    Abstract: The present invention provides compounds and methods for modulating transcription activated by ?-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/?-catenin pathway.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: May 12, 2009
    Assignee: Choongwae Pharma Corporation
    Inventors: Michael Kahn, SeWoong Oh, DaeHoon Kim, JongRyul Ha, Katayoon Hojjati-Emami
  • Modulation of beta-catenin/TCF-activated transcription
    Publication number: 20050059628
    Abstract: The present invention provides compounds and methods for modulating transcription activated by ?-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/?-catenin pathway.
    Type: Application
    Filed: August 27, 2004
    Publication date: March 17, 2005
    Applicant: Choongwae Pharma Corporation
    Inventors: Michael Kahn, SeWoong Oh, DaeHoon Kim, JongRyul Ha, Katayoon Hojjati-Emami